Generally, medical guidelines suggest that GLP-1 medications are appropriate for: Adults with a Body Mass Index (BMI) of 30 or higher
The standard starting dose is 0.25 mg weekly, followed by increases to 0.5 mg, 1.0 mg, 1.7 mg, and potentially 2.4 mg
Chronic conditions require sustained management rather than acute intervention
We considered a subject to have a positive response to GLP-1 M if the median HbA1C within 12 months after the treatment decreased by more than 0.5% from the median HbA1C within 12 months before the treatment [13, 14]
Vittone J, Blackman MR, Busby-Whitehead J, Tsiao C, Stewart KJ, Tobin J, Stevens T, Bellantoni MF, Rogers MA, Baumann G, Roth J, Harman SM, Spencer RG
But fake versions also have surfaced in licensed facilities, the association said